TAMRO Capital Partners’s Gilead Sciences GILD Stock Holding History

TAMRO Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-14,600	Closed	-$1.43M	–	73
2015 Q3	$1.43M	Sell	14,600 -15,173	-51%	-$1.69M	0.16%	54
2015 Q2	$3.49M	Buy	29,773 +5,431	+22%	+$593K	0.3%	60
2015 Q1	$2.39M	Sell	24,342 -10,074	-29%	-$1.02M	0.16%	58
2014 Q4	$3.24M	Sell	34,416 -1,465	-4%	-$152K	0.22%	58
2014 Q3	$3.82M	Sell	35,881 -5,763	-14%	-$564K	0.25%	63
2014 Q2	$3.45M	Buy	41,644 +12,802	+44%	+$996K	0.17%	62
2014 Q1	$2.04M	Buy	28,842 +8,378	+41%	+$657K	0.09%	80
2013 Q4	$1.54M	Buy	+20,464	New	+$1.42M	0.06%	102

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TAMRO Capital Partners's GILD Position: Q4 2015 in Review

TAMRO Capital Partners sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 14,600 shares — an estimated $1.43M sold.

TAMRO Capital Partners first reported a position in GILD in Q4 2013 and held it in 8 quarters. The position peaked at $3.82M in Q3 2014. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

TAMRO Capital Partners reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
TAMRO Capital Partners sold 14,600 Gilead Sciences shares in Q4 2015, an estimated $1.43M.
TAMRO Capital Partners first reported a position in Gilead Sciences in Q4 2013 and held it in 8 quarters.
TAMRO Capital Partners's Gilead Sciences position peaked at $3.82M in Q3 2014.
1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on TAMRO Capital Partners's 13F filing for Q4 2015, filed 21 Jan 2016.